Category: BÜHLMANN Gangliocombi™ MAG ELISA

BUHLMANN Highlights: GanglioCombi™ MAG ELISA

BÜHLMANN GanglioCombi™ MAG ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100476 DOWNLOAD WHITE PAPER BÜHLMANN GanglioCombi™ MAG ELISA Comprehensive assay for anti-MAG and most prevalent anti-Ganglioside antibodies: (GM1, GM2, GD1a, GD1b, and GQ1b). The Neuroimmunology product line by BÜHLMANN is a list of robust assays for simple, esoteric
Continue Reading

High-Dose Rituximab and Anti-MAG-Associated Polyneuropathy

Anti-MAG Autoantibodies ELISA Citation: Renaud S et al.; High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology. 2006 Mar 14; 66(5):742-4. PMID:16534115 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

BÜHLMANN GanglioCombi™ MAG ELISA Utilized in Guillain-Barré Syndrome (GBS) and Zika Virus Study

The BÜHLMANN GanglioCombi™ MAG ELISA was recently utilized in a case-control study in French Polynesia focusing on individuals diagnosed with Guillain-Barré Syndrome (GBS). See publication below: Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study Learn More BÜHLMANN GanglioCombi® MAG ELISA is for Research Use Only. Not for use in diagnostic procedures in
Continue Reading